DBV Technologies | DBVT - Interest Income


DBV Technologies reported $-0.32 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.06M 277K Mar/2026
Alnylam Pharmaceuticals USD 26.6M 32K Mar/2026
Amarin USD 3.37M 3.37M Dec/2024
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
DBV Technologies USD -0.32 0.02 Sep/2024
Galectin Therapeutics USD -2.71M 2.77M Dec/2023
Incyte USD 38.12M 4.43M Jun/2026
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Sarepta Therapeutics USD 7M 1.74M Mar/2026
Ultragenyx Pharmaceutical USD 6M 512K Mar/2026
United Therapeutics USD 31.5M 10.3M Jun/2026